What IO Biotech, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hunter Heidi | Director | May 30 | Open-market buy · P | +15,000 | $1.39 | +$20.9K | 15,000 |
| Sullivan Amy | Chief Financial Officer | Dec 23 | Open-market buy · P | +10,250 | $0.83 | +$8.48K | 84,632 |
| Ahmad Qasim Iftikhar | Chief Medical Officer | Dec 23 | Open-market buy · P | +31,350 | $0.85 | +$26.6K | 31,350 |
| Smith Devin Whittemore | General Counsel | Dec 23 | Open-market buy · P | +12,000 | $0.81 | +$9.72K | 16,938 |
| Zocca Mai-Britt | Chief Executive Officer | Dec 23 | Open-market buy · P | +12,500 | $0.81 | +$10.1K | 49,891 |
| Novo Holdings A/S | 10% owner | Jul 26 | Open-market sale · S | −23,478 | $1.31 | −$30.8K | 4,354,449 |
| Novo Holdings A/S | 10% owner | Jul 25 | Open-market sale · S | −51,522 | $1.33 | −$68.3K | 4,377,927 |
| Novo Holdings A/S | 10% owner | May 10 | Open-market sale · S | −658,809 | $1.22 | −$802K | 4,429,449 |
| Novo Holdings A/S | 10% owner | Feb 09 | Open-market sale · S | −658,809 | $1.50 | −$988K | 5,088,258 |
| Burkavage Brian | Chief Accounting Officer | Nov 22 | Open-market buy · P | +5,000 | $1.04 | +$5.18K | 11,500 |
| Burkavage Brian | Chief Accounting Officer | Nov 21 | Open-market buy · P | +5,000 | $0.99 | +$4.95K | 6,500 |
| Vivo Capital IX, Llc | 10% owner | Aug 09 | Open-market buy · P | +3,157,894 | $1.90 | +$6M | 3,157,894 |
| Smith Devin Whittemore | General Counsel | Aug 09 | Grant / award · A | +4,938 | $1.90 | +$9.38K | 4,938 |
| Elling Christian E | Director | Aug 09 | Grant / award · A | +7,901,234 | $1.90 | +$15M | 13,950,686 |
| Sullivan Amy | Chief Financial Officer | Aug 09 | Grant / award · A | +49,382 | $1.90 | +$93.8K | 74,382 |
| Zocca Mai-Britt | Chief Executive Officer | Aug 09 | Grant / award · A | +37,037 | $1.90 | +$70.4K | 37,391 |
| Lundbeckfond Invest A/S | Director | Aug 09 | Grant / award · A | +7,901,234 | $1.90 | +$15M | 13,950,686 |
| Novo Holdings A/S | 10% owner | Aug 09 | Open-market buy · P | +2,469,135 | $2.03 | +$5M | 5,707,467 |
| Sullivan Amy | Chief Financial Officer | Mar 17 | Open-market buy · P | +25,000 | $2.32 | +$58K | 25,000 |
| Malier Vanessa | Director | Nov 09 | Open-market buy · P | +162,500 | $14.00 | +$2.28M | 430,477 |
Loading...